mannitol has been researched along with fenofibrate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bhatia, G; Pandeti, S; Shukla, A; Sonkar, R; Tadigoppula, N | 1 |
| Bhatia, G; Dodda, RP; Palnati, GR; Sashidhara, KV; Sonkar, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| de Waard, H; Frijlink, HW; Hinrichs, WL | 1 |
| Dong, Y; Hu, J; Ng, WK; Shen, S; Tan, RB | 1 |
| Blanco, M; De Beer, T; de Waard, H; Frijlink, HW; Hinrichs, WL; Remon, JP; Rosas, JG; Vervaet, C | 1 |
| Kleinebudde, P; Lenz, E; Page, S; Sprunk, A | 1 |
| Birch, D; Christophersen, PC; Diedrichsen, RG; Mu, H; Nielsen, HM | 1 |
| Bansal, AK; Thakore, SD; Thakur, PS | 1 |
1 review(s) available for mannitol and fenofibrate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for mannitol and fenofibrate
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.
Topics: Animals; Antioxidants; Disease Models, Animal; Diterpenes; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Molecular Structure; Oxidation-Reduction; Rats; Rats, Inbred Strains | 2013 |
Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
Topics: Animals; Antioxidants; Chalcone; Disease Models, Animal; Drug Design; Hyperlipidemias; Hypolipidemic Agents; Indoles; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Molecular Structure; Polyethylene Glycols; Rats | 2014 |
A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying.
Topics: Calorimetry, Differential Scanning; Crystallization; Fenofibrate; Freeze Drying; Freezing; Hypolipidemic Agents; Kinetics; Mannitol; Microscopy, Electron, Scanning; Nanoparticles; Solvents; Tablets; tert-Butyl Alcohol; Water; X-Ray Diffraction | 2008 |
Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Topics: Calorimetry, Differential Scanning; Chemical Precipitation; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Excipients; Feasibility Studies; Fenofibrate; Hypolipidemic Agents; Hypromellose Derivatives; Kinetics; Lactose; Light; Mannitol; Methylcellulose; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Polysorbates; Powders; Scattering, Radiation; Sodium Dodecyl Sulfate; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
NIR spectroscopy for the in-line monitoring of a multicomponent formulation during the entire freeze-drying process.
Topics: Chemistry, Pharmaceutical; Crystallization; Fenofibrate; Freeze Drying; Mannitol; Principal Component Analysis; Solutions; Spectroscopy, Near-Infrared; tert-Butyl Alcohol; Water; X-Ray Diffraction | 2014 |
Impact of fillers on dissolution kinetic of fenofibrate dry foams.
Topics: Disaccharides; Excipients; Fenofibrate; Glucose; Hypolipidemic Agents; Kinetics; Mannitol; Particle Size; Phosphatidylcholines; Solubility; Starch; Sugar Alcohols; Tablets; Technology, Pharmaceutical | 2015 |
Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Topics: Caco-2 Cells; Cell Survival; Coculture Techniques; Cyclosporine; Deamino Arginine Vasopressin; Fenofibrate; HT29 Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mannitol; Metoprolol; Models, Biological; Mucus; Ovalbumin; Permeability | 2018 |
Role of Surface Characteristics of Mannitol in Crystallization of Fenofibrate During Spray Drying.
Topics: Crystallization; Excipients; Fenofibrate; Mannitol; Solubility; Spray Drying | 2020 |